[Auto-immune diseases and immunodepressive therapy. II. Current clinical indications].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001167:Arteritis / Q000188:drug therapy; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001379:Azathioprine / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003424:Crohn Disease / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D003882:Dermatomyositis / Q000188:drug therapy; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008107:Liver Diseases / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D009422:Nervous System Diseases / Q000188:drug therapy; D010488:Polyarteritis Nodosa / Q000188:drug therapy; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000188:drug therapy; D012859:Sjogren's Syndrome / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D001379:Azathioprine
Maladies auto-immunitaires et traitement immunodepresseur. II. Indications actuelles en clinique